Home Page |
References | OMIM | Gene | GeneReviews | HGMD | HGNC |
GENATLAS PHENOTYPE |
last update : 21-08-2015 |
Symbol | PARK1 |
Location | 4q22.1 |
Name | Parkinson disease, 1 |
Other name(s) | Lewy body parkinsonism |
Corresponding gene | SNCA |
Other symbol(s) | PRKSD1, D4S3159, PARK4 |
Main clinical features |
|
Genetic determination | autosomal dominant |
Prevalence | early onset PD autosomal dominant and sporadic |
Related entries | . including familial and sporadic dementia with Lewy bodies and multiple system atrophy (Omim: 127750) . including Parkinson disease with autonomic dysfunction and ataxia . infantile neurodegeneration with iron accumulation in the brain |
Function/system disorder | neurology |
Type | disease |
Gene product |
Name | alpha synuclein (SNCA), major component of Lewy bodies and Lewy neurites |
Mechanism(s) |
Gene mutation | Chromosome rearrangement | Effect | Comments |
| missense
|  
|  
| A53T, with mitochondrial dysfunction and ER stress, contributing to neuronal cell death
| missense
|  
|  
| A53T, A30P, and E46K, extremely rare
| amplification
|  
|  
| duplication and triplication of the 4q21 locus including SNCA,suggesting a dosage effect (PARK4), in ~2 percent of familial PD cases
| other
|  
|  
| susceptibility variants
| |
Remark(s) |